| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |